Total planned funding: $323,554,022
Allocations
Countries/Regions
Eswatini | $323,554,022 |
Organizational Types
Private Contractor | $80,301,896 |
Unknown | $63,101,558 |
University | $57,755,746 |
NGO | $55,413,603 |
Own Agency | $39,196,826 |
Host Country Government Agency | $11,382,247 |
FBO | $10,806,488 |
Multi-lateral Agency | $3,030,564 |
Other USG Agency | $2,515,094 |
Implementing Agency | $50,000 |
Program Areas
Care | $95,660,646 |
Treatment | $81,399,808 |
Prevention | $60,386,541 |
Governance and Systems | $39,024,291 |
Testing | $24,356,698 |
Management and Operations | $22,726,038 |
Budget Codes
HTXS: Treatment: Adult Treatment | $68,224,454 |
HBHC: Care: Adult Care and Support | $36,435,268 |
HKID: Care: Orphans and Vulnerable Children | $32,937,220 |
HVCT: Testing: HIV Testing and Counseling | $24,356,698 |
HVMS: Management and Operations | $22,726,038 |
HVOP: Sexual Prevention: Other Sexual Prevention | $21,474,815 |
HVSI: Strategic Information | $19,818,605 |
HVTB: Care: TB/HIV | $18,608,615 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $18,539,990 |
OHSS: Health Systems Strengthening | $13,236,634 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $9,808,127 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $9,601,609 |
PDTX: Treatment: Pediatric Treatment | $8,359,376 |
PDCS: Care: Pediatric Care and Support | $7,679,543 |
HLAB: Laboratory Infrastructure | $5,969,052 |
HTXD: Treatment: ARV Drugs | $4,815,978 |
HMBL: Biomedical Prevention: Blood Safety | $962,000 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$46,572,370
Countries/Regions
Not Available:
$44,791,692
Countries/Regions
Pact, Inc.:
$37,668,259
Countries/Regions
Chemonics International:
$16,579,695
Countries/Regions